Drug Reference
Sofosbuvir / Velpatasvir
Antivirals for treatment of HCV infections
Fact box
- Therapeutic class
- Antivirals for treatment of HCV infections
Brand names
Epclusa
Available as
400 MG · Oral Tablet200 MG · Oral Tablet150 MG200 MG
Multi-ingredient product
SofosbuvirVelpatasvir
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- EPCLUSA ACCESS (VELPATASVIR AND SOFOSBUVIR) TABLET, FILM COATED [GILEAD SCIENCES, INC.]
- SOFOSBUVIR AND VELPATASVIR (VELPATASVIR AND SOFOSBUVIR) TABLET, FILM COATED [ASEGUA THERAPEUTICS LLC]
- EPCLUSA (VELPATASVIR AND SOFOSBUVIR) TABLET, FILM COATED EPCLUSA (VELPATASVIR AND SOFOSBUVIR) PELLET [GILEAD SCIENCES, INC.]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.